$1.92 Billion is the total value of SABBY MANAGEMENT, LLC's 287 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PRSNW | Exit | PERSEON EQUITY WARRANTS*w | $0 | – | -1,887,892 | -100.0% | 0.00% | – |
| OPXAW | Exit | OPEXA THERAPEUTICS EQUITY WARRANTS*w | $0 | – | -34,097 | -100.0% | 0.00% | – |
| RNVA | Exit | RENNOVA HEALTH INC | $0 | – | -30,761 | -100.0% | -0.00% | – |
| Exit | ANTARES PHARMA INCcall | $0 | – | -399 | -100.0% | -0.00% | – | |
| Exit | BRAINSTORM CELL THERAPEUTICS INCcall | $0 | – | -175 | -100.0% | -0.00% | – | |
| Exit | CYTRX CORP INCcall | $0 | – | -170 | -100.0% | -0.00% | – | |
| Exit | TONIX PHARMACEUTICALS HOLDING CORPcall | $0 | – | -148 | -100.0% | -0.00% | – | |
| Exit | AVALANCHE BIOTECHNOLOGIES INCcall | $0 | – | -106 | -100.0% | -0.00% | – | |
| Exit | AKEBIA THERAPEUTICS INCcall | $0 | – | -100 | -100.0% | -0.01% | – | |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -67,534 | -100.0% | -0.01% | – |
| BIOD | Exit | BIODEL INC | $0 | – | -357,500 | -100.0% | -0.01% | – |
| Exit | TRILLIUM THERAPEUTICS INC | $0 | – | -14,137 | -100.0% | -0.01% | – | |
| Exit | NXSTAGE MEDICAL INCput | $0 | – | -100 | -100.0% | -0.01% | – | |
| CERE | Exit | CERES INC. | $0 | – | -720,378 | -100.0% | -0.01% | – |
| Exit | SYNERGY PHARMACEUTICALS EQUITY WARRANTS*w | $0 | – | -285,414 | -100.0% | -0.01% | – | |
| ARQL | Exit | ARQULE INC | $0 | – | -100,000 | -100.0% | -0.01% | – |
| ALDX | Exit | ALDEYRA THERAPEUTICS INC | $0 | – | -41,096 | -100.0% | -0.01% | – |
| ARDX | Exit | ARDELYX INC | $0 | – | -22,278 | -100.0% | -0.01% | – |
| LPTN | Exit | LPATH INC | $0 | – | -1,106,870 | -100.0% | -0.01% | – |
| Exit | TRANSENTERIX INCput | $0 | – | -482 | -100.0% | -0.01% | – | |
| Exit | HERON THERAPEUTICS INCcall | $0 | – | -126 | -100.0% | -0.01% | – | |
| NSPH | Exit | NANOSPHERE ORD SHS | $0 | – | -308,147 | -100.0% | -0.01% | – |
| CLRB | Exit | CELLECTAR BIOSCIENCES INC | $0 | – | -71,313 | -100.0% | -0.01% | – |
| Exit | THERAPEUTICSMD INCput | $0 | – | -404 | -100.0% | -0.01% | – | |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -7,002 | -100.0% | -0.01% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -53,620 | -100.0% | -0.01% | – |
| Exit | LIPOCINE INCcall | $0 | – | -350 | -100.0% | -0.02% | – | |
| EBIO | Exit | ELEVEN BIOTHERAPEUTICS INC | $0 | – | -1,213,984 | -100.0% | -0.02% | – |
| THLD | Exit | THRESHOLD PHARMACEUTICALS INC | $0 | – | -837,904 | -100.0% | -0.02% | – |
| PSTI | Exit | PLURISTEM THERAPEUTICS INC | $0 | – | -251,020 | -100.0% | -0.02% | – |
| Exit | EAGLE PHARMACEUTICALS INCput | $0 | – | -100 | -100.0% | -0.02% | – | |
| Exit | REGULUS THERAPEUTIC INCput | $0 | – | -574 | -100.0% | -0.02% | – | |
| Exit | SPECTRANETICS CORPcall | $0 | – | -279 | -100.0% | -0.02% | – | |
| TROV | Exit | TROVAGENE INC | $0 | – | -85,000 | -100.0% | -0.02% | – |
| NSPR | Exit | INSPIREMD INC | $0 | – | -790,538 | -100.0% | -0.02% | – |
| EGRX | Exit | EAGLE PHARMACEUTICALS INC | $0 | – | -10,000 | -100.0% | -0.02% | – |
| Exit | VALEANT PHARMACEUTICALS INTERNATIONAL INCcall | $0 | – | -149 | -100.0% | -0.02% | – | |
| KOOL | Exit | CESCA THERAPEUTICS ORD SHS | $0 | – | -111,094 | -100.0% | -0.02% | – |
| SENS | Exit | SENSEONICS HOLDINGS INC | $0 | – | -153,900 | -100.0% | -0.02% | – |
| Exit | GILEAD SCIENCES INCput | $0 | – | -50 | -100.0% | -0.02% | – | |
| ALKS | Exit | ALKERMES PLC | $0 | – | -15,000 | -100.0% | -0.03% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -29,624 | -100.0% | -0.03% | – |
| HALO | Exit | HALOZYME THERAPEUTICS INC | $0 | – | -60,000 | -100.0% | -0.03% | – |
| CYCC | Exit | CYCLACEL PHARMACEUTICALS INC | $0 | – | -1,632,259 | -100.0% | -0.03% | – |
| HTBX | Exit | HEAT BIOLOGICS INC | $0 | – | -902,007 | -100.0% | -0.03% | – |
| Exit | OMEROS CORPcall | $0 | – | -415 | -100.0% | -0.03% | – | |
| NTRA | Exit | NATERA INC | $0 | – | -69,272 | -100.0% | -0.03% | – |
| BLCM | Exit | BELLICUM PHARMACEUTICALS INC | $0 | – | -77,020 | -100.0% | -0.04% | – |
| OTIC | Exit | OTONOMY INC | $0 | – | -50,000 | -100.0% | -0.04% | – |
| Exit | CYTOKINETICS INCcall | $0 | – | -1,066 | -100.0% | -0.04% | – | |
| Exit | ARIAD PHARMACEUTICALS INCcall | $0 | – | -1,265 | -100.0% | -0.04% | – | |
| TBRA | Exit | TOBIRA THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.04% | – |
| ACHN | Exit | ACHILLION PHARMACEUTICALS INC | $0 | – | -105,648 | -100.0% | -0.04% | – |
| SGMO | Exit | SANGAMO BIOSCIENCES INC | $0 | – | -134,500 | -100.0% | -0.04% | – |
| TXMD | Exit | THERAPEUTICSMD INC | $0 | – | -130,400 | -100.0% | -0.04% | – |
| Exit | INTERCEPT PHARMACEUTICALS INCput | $0 | – | -72 | -100.0% | -0.05% | – | |
| ONTY | Exit | ONCOTHYREON INC | $0 | – | -739,004 | -100.0% | -0.05% | – |
| DSCO | Exit | DISCOVERY LABORATORIES INC | $0 | – | -566,352 | -100.0% | -0.05% | – |
| Exit | MANNKIND CORPcall | $0 | – | -6,000 | -100.0% | -0.05% | – | |
| MSTX | Exit | MAST THERAPEUTICS INC | $0 | – | -3,877,356 | -100.0% | -0.05% | – |
| SGYPQ | Exit | SYNERGY PHARMACEUTICALS INC | $0 | – | -392,273 | -100.0% | -0.05% | – |
| FLDM | Exit | FLUIDIGM INC | $0 | – | -139,506 | -100.0% | -0.06% | – |
| MDGNWS | Exit | MEDGENICS EQUITY WARRANTS EXP 13 FEB 2018*w | $0 | – | -1,564,370 | -100.0% | -0.06% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -56,400 | -100.0% | -0.06% | – |
| AKRXQ | Exit | AKORN INC | $0 | – | -53,729 | -100.0% | -0.06% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -46,258 | -100.0% | -0.06% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -50,000 | -100.0% | -0.07% | – |
| AMRN | Exit | AMARIN CORP PLCadr | $0 | – | -870,792 | -100.0% | -0.07% | – |
| TTOO | Exit | T2 BIOSYSTEMS INC | $0 | – | -145,000 | -100.0% | -0.07% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INCcall | $0 | – | -365 | -100.0% | -0.07% | – |
| DEPO | Exit | DEPOMED INC | $0 | – | -106,057 | -100.0% | -0.07% | – |
| PRTA | Exit | PROTHENA CORP PLC | $0 | – | -40,000 | -100.0% | -0.08% | – |
| RLYP | Exit | RELYPSA INC | $0 | – | -122,905 | -100.0% | -0.08% | – |
| Exit | BRISTOL-MYERS SQUIBB COcall | $0 | – | -264 | -100.0% | -0.08% | – | |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -24,603 | -100.0% | -0.09% | – |
| CRDC | Exit | CARDICA INC | $0 | – | -498,600 | -100.0% | -0.09% | – |
| VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -23,320 | -100.0% | -0.09% | – |
| Exit | MEDICINES CO 01JUN17 1.375%dbcv | $0 | – | -1,500,000 | -100.0% | -0.10% | – | |
| Exit | AKORN INCcall | $0 | – | -815 | -100.0% | -0.10% | – | |
| OASMY | Exit | OASMIA PHARMACEUTICAL ABadr | $0 | – | -477,836 | -100.0% | -0.10% | – |
| RDUS | Exit | RADIUS HEALTH INC | $0 | – | -65,000 | -100.0% | -0.10% | – |
| Exit | ADVAXIS INCcall | $0 | – | -2,325 | -100.0% | -0.10% | – | |
| RTRX | Exit | RETROPHIN INC | $0 | – | -156,774 | -100.0% | -0.11% | – |
| DBVT | Exit | DBV TECHNOLOGIES S A | $0 | – | -70,000 | -100.0% | -0.11% | – |
| ANAC | Exit | ANACOR PHARMACEUTICALS INC | $0 | – | -44,439 | -100.0% | -0.12% | – |
| Exit | TRANSENTERIX INCcall | $0 | – | -5,916 | -100.0% | -0.13% | – | |
| Exit | SYNERGY PHARMACEUTICALS INCcall | $0 | – | -9,727 | -100.0% | -0.13% | – | |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -70,000 | -100.0% | -0.14% | – |
| AAVL | Exit | AVALANCHE BIOTECHNOLOGIES INC | $0 | – | -540,632 | -100.0% | -0.14% | – |
| Exit | AKORN INCput | $0 | – | -1,194 | -100.0% | -0.14% | – | |
| ESRX | Exit | EXPRESS SCRIPTS HOLDING CO | $0 | – | -41,311 | -100.0% | -0.14% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -27,856 | -100.0% | -0.19% | – |
| Exit | EAGLE PHARMACEUTICALS INCcall | $0 | – | -1,000 | -100.0% | -0.20% | – | |
| Exit | ALEXION PHARMACEUTICALS INCput | $0 | – | -342 | -100.0% | -0.24% | – | |
| Exit | BLUEPRINT MEDICINES CORPcall | $0 | – | -3,000 | -100.0% | -0.27% | – | |
| Exit | BIOMARIN PHARMACEUTICAL 0.75%note | $0 | – | -5,000,000 | -100.0% | -0.29% | – | |
| Exit | ANACOR PHARMACEUTICALS INCcall | $0 | – | -1,214 | -100.0% | -0.32% | – | |
| Exit | GW PHARMACEUTICALS PLCput | $0 | – | -908 | -100.0% | -0.33% | – | |
| Exit | PORTOLA PHARMACEUTICALS INCcall | $0 | – | -3,221 | -100.0% | -0.33% | – | |
| Exit | LINKEDIN CORPcall | $0 | – | -579 | -100.0% | -0.33% | – | |
| Exit | EXPRESS SCRIPTS HOLDING COput | $0 | – | -1,064 | -100.0% | -0.37% | – | |
| Exit | UNITED THERAPEUTICS CORPcall | $0 | – | -750 | -100.0% | -0.42% | – | |
| CYTX | Exit | CYTORI THERAPEUTICS INC | $0 | – | -7,305,690 | -100.0% | -0.72% | – |
| Exit | EDWARDS LIFESCIENCES CORPput | $0 | – | -2,201 | -100.0% | -0.97% | – | |
| Exit | EDWARDS LIFESCIENCES CORPcall | $0 | – | -2,477 | -100.0% | -1.09% | – | |
| Exit | JOHNSON & JOHNSONput | $0 | – | -2,061 | -100.0% | -1.12% | – | |
| SPY | Exit | SPDR S&P 500 ETF TRUSTunit | $0 | – | -108,899 | -100.0% | -1.12% | – |
| Exit | GILEAD SCIENCES INCcall | $0 | – | -8,440 | -100.0% | -3.88% | – | |
| Exit | ISHARES RUSSELL 2000 ETFput | $0 | – | -17,673 | -100.0% | -8.12% | – | |
| IMMU | Exit | IMMUNOMEDICS 15FEB20 4.75PCTnote | $0 | – | -2,680,000 | -100.0% | -9.12% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-08-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
| ISHARES TR | 35 | Q3 2023 | 52.2% |
| SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
| AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
| BIOGEN INC | 24 | Q1 2021 | 26.2% |
| SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
| BIOGEN INC | 23 | Q1 2021 | 13.7% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
| BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
| VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
| Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
| Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
| Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
| HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
| PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
| Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
| TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
| Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
| TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-04 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
| SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.